CDRH Contemplating A New Pre-market Review Division
This article was originally published in The Gray Sheet
Executive Summary
FDA's device center is considering adding a new division within its Office of Device Evaluation to improve workload distribution, CDRH Director Jeffrey Shuren said May 5.
You may also be interested in...
Regulatory News In Brief
Transvaginal surgical mesh scrutiny
Regulatory News In Brief
Transvaginal surgical mesh scrutiny
CDRH Reorganization Proposal Would Add "Sorely Needed" Managers
FDA’s device center is considering bringing on more managers to oversee device and diagnostic reviewers.